These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24601954)

  • 1. Down-regulation of serum gonadotropins but not estrogen replacement improves cognition in aged-ovariectomized 3xTg AD female mice.
    Palm R; Chang J; Blair J; Garcia-Mesa Y; Lee HG; Castellani RJ; Smith MA; Zhu X; Casadesus G
    J Neurochem; 2014 Jul; 130(1):115-25. PubMed ID: 24601954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of serum gonadotropins is as effective as estrogen replacement at improving menopause-associated cognitive deficits.
    Bryan KJ; Mudd JC; Richardson SL; Chang J; Lee HG; Zhu X; Smith MA; Casadesus G
    J Neurochem; 2010 Feb; 112(4):870-81. PubMed ID: 19943850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing luteinizing hormone levels after ovariectomy improves spatial memory: Possible role of brain-derived neurotrophic factor.
    Bohm-Levine N; Goldberg AR; Mariani M; Frankfurt M; Thornton J
    Horm Behav; 2020 Feb; 118():104590. PubMed ID: 31593698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteinizing hormone downregulation but not estrogen replacement improves ovariectomy-associated cognition and spine density loss independently of treatment onset timing.
    Blair JA; Palm R; Chang J; McGee H; Zhu X; Wang X; Casadesus G
    Horm Behav; 2016 Feb; 78():60-6. PubMed ID: 26497249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical exercise neuroprotects ovariectomized 3xTg-AD mice through BDNF mechanisms.
    García-Mesa Y; Pareja-Galeano H; Bonet-Costa V; Revilla S; Gómez-Cabrera MC; Gambini J; Giménez-Llort L; Cristòfol R; Viña J; Sanfeliu C
    Psychoneuroendocrinology; 2014 Jul; 45():154-66. PubMed ID: 24845186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS luteinizing hormone receptor activation rescues ovariectomy-related loss of spatial memory and neuronal plasticity.
    Blair JA; Bhatta S; Casadesus G
    Neurobiol Aging; 2019 Jun; 78():111-120. PubMed ID: 30925299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
    Casadesus G; Garrett MR; Webber KM; Hartzler AW; Atwood CS; Perry G; Bowen RL; Smith MA
    Drugs R D; 2006; 7(3):187-93. PubMed ID: 16752944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative contribution of estrogen withdrawal and gonadotropins increase secondary to ovariectomy on prostaglandin generation in mesenteric microvessels.
    Dantas AP; Franco Mdo C; Tostes RC; Fortes ZB; Costa SG; Nigro D; Carvalho MH
    J Cardiovasc Pharmacol; 2004 Jan; 43(1):48-55. PubMed ID: 14668567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovariectomy-induced hormone deprivation aggravates Aβ
    Farkas S; Szabó A; Török B; Sólyomvári C; Fazekas CL; Bánrévi K; Correia P; Chaves T; Zelena D
    Front Endocrinol (Lausanne); 2022; 13():985424. PubMed ID: 36303870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low luteinizing hormone enhances spatial memory and has protective effects on memory loss in rats.
    Ziegler SG; Thornton JE
    Horm Behav; 2010 Nov; 58(5):705-13. PubMed ID: 20691694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone: Evidence for direct action in the CNS.
    Blair JA; Bhatta S; McGee H; Casadesus G
    Horm Behav; 2015 Nov; 76():57-62. PubMed ID: 26172857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice.
    Carroll JC; Rosario ER; Chang L; Stanczyk FZ; Oddo S; LaFerla FM; Pike CJ
    J Neurosci; 2007 Nov; 27(48):13357-65. PubMed ID: 18045930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.
    Bowen RL; Verdile G; Liu T; Parlow AF; Perry G; Smith MA; Martins RN; Atwood CS
    J Biol Chem; 2004 May; 279(19):20539-45. PubMed ID: 14871891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hypersecretion of luteinizing hormone in transgenic mice selectively alters responsiveness of the alpha-subunit gene to gonadotropin-releasing hormone and estrogens.
    Abbud RA; Ameduri RK; Rao JS; Nett TM; Nilson JH
    Mol Endocrinol; 1999 Sep; 13(9):1449-59. PubMed ID: 10478837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone acts at the hippocampus to dampen spatial memory.
    Burnham V; Sundby C; Laman-Maharg A; Thornton J
    Horm Behav; 2017 Mar; 89():55-63. PubMed ID: 27847314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic low dose of AM404 ameliorates the cognitive impairment and pathological features in hyperglycemic 3xTg-AD mice.
    Huang HJ; Chen SL; Huang HY; Sun YC; Lee GC; Lee-Chen GJ; Hsieh-Li HM; Su MT
    Psychopharmacology (Berl); 2019 Feb; 236(2):763-773. PubMed ID: 30426182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease.
    Velazquez R; Shaw DM; Caccamo A; Oddo S
    Mol Neurodegener; 2016 Jul; 11(1):52. PubMed ID: 27412291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.